Skip to content
ProPublica Donate
ProPublica Donate

American Society For Clinical Pharmacology & Therapeutics

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Health — General and Rehabilitative / Health Support Services (E66Z) (NTEE)

Donations to this organization are tax deductible.

Details

According to its Dec. 2023 tax filing, this nonprofit:

Reported conflict of interest transactions
Organizations must report loans, grants or business transactions with interested parties, which may include key employees and officers, their family members and any businesses in which they hold a controlling interest. These transactions must be reported on Schedule L.

Summary charts: organization finances over time

Revenue
$3.7M (2023)

Expenses
$4.05M (2023)

Total Assets
$6.49M (2023)

Total Liabilities
$0 (2023)

Source: Form 990 tax filings from 2011 to 2023

Tax Filings by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Fiscal Year Ending Dec.
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$3,700,370
Expenses
$4,053,559
Net Income
-$353,189
Net Assets
$6,491,449
Notable Sources of Revenue Percent of Total Revenue
Contributions $58,535
1.6%
Program Services $3,514,192
95.0%
Investment Income $107,874
2.9%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $12,359
0.3%
Net Inventory Sales $0
Other Revenue $7,410
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $716,300
17.7%
Professional Fundraising Fees $0
Other Salaries and Wages $902,196
22.3%
Assets/Debt
Total Assets $6,491,449
Total Liabilities $0
Net Assets $6,491,449
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Abigail Gorman (Chief Executive Officer) $366,589 $0 $41,665
Elise Laffman Johnson (Chief Operating Officer) $281,675 $0 $24,449
Lisa Infelise (Sr Dir, Mbr Svcs) $165,789 $0 $24,191
Alethea Gerding (Managing Editor) $143,521 $0 $12,350
Walter Kraft (President) $0 $0 $0
Mark J Dresser (Immediate Past President) $0 $0 $0
Matthew L Rizk (President Elect) $0 $0 $0
Jacques Turgeon (Treasurer) $0 $0 $0
Antoinette Toni Ajavon Hartmann (Director) $0 $0 $0
Lisa J Benincosa (Director) $0 $0 $0
Jing Liu (Director) $0 $0 $0
Kathryn Momary (Director) $0 $0 $0
Daniele Ouellet (Director) $0 $0 $0
Luana Pesco Koplowitz (Director) $0 $0 $0
Anu Ramamoorthy (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$3,625,776
Expenses
$3,254,073
Net Income
$371,703
Net Assets
$6,502,007
Notable Sources of Revenue Percent of Total Revenue
Contributions $88,469
2.4%
Program Services $3,456,290
95.3%
Investment Income $63,603
1.8%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $13,599
0.4%
Net Inventory Sales $0
Other Revenue $3,815
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $896,180
27.5%
Professional Fundraising Fees $9,907
0.3%
Other Salaries and Wages $828,472
25.5%
Assets/Debt
Total Assets $6,502,007
Total Liabilities $0
Net Assets $6,502,007
Compensation
Key Employees and Officers Compensation Related Other
Sharon Swan (Chief Executive Officer(thru 12/22)) $547,564 $0 $76,325
Elise Laffman Johnson (Chief Operating Officer) $247,265 $0 $23,149
Lisa Infelise (Sr Dir, Mbr Svcs) $148,322 $0 $20,703
Alethea Gerding (Managing Editor) $125,519 $0 $10,949
Mark Dresser Phd (President) $0 $0 $0
Jacques Turgeon Phd (Treasurer) $0 $0 $0
Walter Kraft (President Elect) $0 $0 $0
Issam Zineh Pharmd (Immediate Past President) $0 $0 $0
Antoinette Toni Ajavon Hartmann Ph (Director) $0 $0 $0
Lisa J Benincosa Phd (Director) $0 $0 $0
Donald Heald Phd (Director) $0 $0 $0
Steven Kern Phd (Director) $0 $0 $0
Daniele Ouellet Phd (Director) $0 $0 $0
Luana Pesco Koplowitz Md Phd (Director) $0 $0 $0
Matthew L Rizk Phd (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$4,282,201
Expenses
$3,287,407
Net Income
$994,794
Net Assets
$6,637,281
Notable Sources of Revenue Percent of Total Revenue
Contributions $252,731
5.9%
Program Services $3,948,116
92.2%
Investment Income $54,802
1.3%
Bond Proceeds $0
Royalties $34,021
0.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$8,375
Net Inventory Sales $0
Other Revenue $906
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $808,356
24.6%
Professional Fundraising Fees $0
Other Salaries and Wages $767,207
23.3%
Assets/Debt
Total Assets $6,637,281
Total Liabilities $0
Net Assets $6,637,281
Compensation
Key Employees and Officers Compensation Related Other
Sharon Swan (Chief Executive Officer) $466,328 $0 $96,420
Elise Laffman Johnson (Chief Operating Officer) $229,946 $0 $14,132
Lisa Infelise (Sr Dir, Mbr Svcs) $139,914 $0 $16,351
Alethea Gerding (Managing Editor) $104,732 $0 $3,651
Issam Zineh Pharmd (President) $0 $0 $0
Jacques Turgeon Phd (Treasurer) $0 $0 $0
Mark Dresser Phd (President Elect) $0 $0 $0
Susan Abdel Rahman Pharmd (Immediate Past President) $0 $0 $0
Michelle Rudek Pharmd Phd (Director) $0 $0 $0
Tamorah Lewis Md Phd (Director) $0 $0 $0
Matthew Rizk Phd (Director) $0 $0 $0
Donald Heald Phd (Director) $0 $0 $0
Luana Pesco Koplowitz Md Phd (Director) $0 $0 $0
Steven Kern Phd (Director) $0 $0 $0
Daniele Ouellet Phd (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$2,105,682
Expenses
$2,668,717
Net Income
-$563,035
Net Assets
$5,298,284
Notable Sources of Revenue Percent of Total Revenue
Contributions $267,198
12.7%
Program Services $1,700,352
80.8%
Investment Income $51,959
2.5%
Bond Proceeds $0
Royalties $22,327
1.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $58,715
2.8%
Net Inventory Sales $0
Other Revenue $5,131
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $677,209
25.4%
Professional Fundraising Fees $0
Other Salaries and Wages $638,282
23.9%
Assets/Debt
Total Assets $5,298,284
Total Liabilities $0
Net Assets $5,298,284
Compensation
Key Employees and Officers Compensation Related Other
Sharon Swan (Chief Executive Officer) $412,822 $0 $48,153
Elise Laffman Johnson (Chief Operating Officer) $200,385 $0 $14,319
Lisa Infelise (Sr Dir, Mbr Svcs) $120,377 $0 $13,846
Susan Abdel Rahman Pharmd (President) $0 $0 $0
Jacques Turgeon Phd (Treasurer) $0 $0 $0
Issam Zineh Pharmd (President Elect) $0 $0 $0
David Mitchell Phd (Immediate Past President) $0 $0 $0
Brian Corrigan Phd (Director) $0 $0 $0
Donald Heald Phd (Director) $0 $0 $0
Lei Zhang Phd (Director) $0 $0 $0
Mark Dresser Phd (Director) $0 $0 $0
Matthew Rizk Phd (Director) $0 $0 $0
Michelle Rudek Pharmd Phd (Director) $0 $0 $0
Tamorah Lewis Md Phd (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$4,011,186
Expenses
$3,682,303
Net Income
$328,883
Net Assets
$5,765,207
Notable Sources of Revenue Percent of Total Revenue
Contributions $41,857
1.0%
Program Services $3,845,106
95.9%
Investment Income $71,005
1.8%
Bond Proceeds $0
Royalties $28,419
0.7%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $23,070
0.6%
Net Inventory Sales $0
Other Revenue $1,729
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $713,395
19.4%
Professional Fundraising Fees $0
Other Salaries and Wages $624,635
17.0%
Assets/Debt
Total Assets $5,817,074
Total Liabilities $51,867
Net Assets $5,765,207
Compensation
Key Employees and Officers Compensation Related Other
Sharon J Swan Fasae Cae (Ceo) $434,781 $0 $62,000
Elise Laffman Johnson (Coo) $202,500 $0 $12,635
Lisa M Infelise (Sr Dir, Mbr Svcs) $118,437 $0 $12,012
David Mitchell (President (As Of 3/2019)) $0 $0 $0
Susan Abdel Rahman (President Elect (As Of 3/2019)) $0 $0 $0
Jacques Turgeon (Treasurer (As Of 3/2019)) $0 $0 $0
Dan Hartman (Immed. Past President (As Of 3/2019)) $0 $0 $0
Brian Corrigan (Board Member) $0 $0 $0
Lei Zhang (Board Member) $0 $0 $0
Tamorah Lewis (Board Member (As Of 3/2019)) $0 $0 $0
Michelle Rudek (Board Member (As Of 3/2019)) $0 $0 $0
Jill Fiedler Kelly (Board Member) $0 $0 $0
Jean Michel Gries (Board Member) $0 $0 $0
Paolo Vicini (Board Member) $0 $0 $0
Walter Kraft (Treasurer (Thru 3/2019)) $0 $0 $0
Kellie Schoolar Reynolds (Immed. Past President (Thru 3/2019)) $0 $0 $0
Virginia Schmith (Board Member (Thru 3/2019)) $0 $0 $0
Aubrey Stoch (Board Member (Thru 3/2019)) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$3,798,624
Expenses
$3,575,493
Net Income
$223,131
Net Assets
$5,139,980
Notable Sources of Revenue Percent of Total Revenue
Contributions $168,372
4.4%
Program Services $3,491,284
91.9%
Investment Income $57,290
1.5%
Bond Proceeds $0
Royalties $22,695
0.6%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $56,931
1.5%
Net Inventory Sales $0
Other Revenue $2,052
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $662,711
18.5%
Professional Fundraising Fees $0
Other Salaries and Wages $681,262
19.1%
Assets/Debt
Total Assets $5,194,739
Total Liabilities $54,759
Net Assets $5,139,980
Compensation
Key Employees and Officers Compensation Related Other
Sharon J Swan Fasae Cae (Ceo) $405,850 $0 $64,264
Elise Laffman Johnson (Coo) $177,962 $0 $13,156
Lisa M Infelise (Senior Director Of Member Services) $115,345 $0 $11,795
Emma Shumeyko (Managing Editor) $107,572 $0 $11,004
Dan Hartman Md (President (As Of 3/2018)) $0 $0 $0
Kellie Schoolar Reynolds Pharmd (Immed. Past President (As Of 3/2018)) $0 $0 $0
David Y Mitchell Phd (President Elect (As Of 3/2018)) $0 $0 $0
Walter Kraft Md Facp (Treasurer) $0 $0 $0
Brian W Corrigan Phd (Director (As Of 3/2018)) $0 $0 $0
Jill Fiedler Kelly Ms (Director) $0 $0 $0
Jean Michel Gries Phd Pharmd (Director (As Of 3/2018)) $0 $0 $0
Virginia Ginny D Schmith Phd Fcp (Director) $0 $0 $0
Aubrey Stoch Md (Director) $0 $0 $0
Paolo Vicini Phd Mba (Director) $0 $0 $0
Lei Zhang Phd (Director (As Of 3/2018)) $0 $0 $0
Julie A Johnson Pharmd (Immed. Past President (To 3/2018)) $0 $0 $0
Anne C Heatherington Phd (Director (To 3/2018)) $0 $0 $0
Sean Hennessy Pharmd Phd (Director (To 3/2018)) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$3,489,349
Expenses
$3,673,213
Net Income
-$183,864
Net Assets
$5,102,287
Notable Sources of Revenue Percent of Total Revenue
Contributions $60,695
1.7%
Program Services $3,285,136
94.1%
Investment Income $59,470
1.7%
Bond Proceeds $0
Royalties $29,433
0.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $51,534
1.5%
Net Inventory Sales $0
Other Revenue $3,081
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $569,532
15.5%
Professional Fundraising Fees $0
Other Salaries and Wages $709,309
19.3%
Assets/Debt
Total Assets $5,142,500
Total Liabilities $40,213
Net Assets $5,102,287
Compensation
Key Employees and Officers Compensation Related Other
Sharon Swan (Chief Executive Officer) $371,178 $0 $27,932
Elise Laffman Johnson (Chief Operating Officer) $167,000 $0 $0
Lisa Williamson (Senior Director Of Member Services) $114,190 $0 $6,324
Emma Shumeyko (Managing Editor) $105,769 $0 $0
Julie A Johnson Pharmd (President) $0 $0 $0
Dan Hartman (President Elect) $0 $0 $0
Jill Fiedler Kelly (Director) $0 $0 $0
Walter Kraft Md (Secretary/Treasurer) $0 $0 $0
Paolo Vicini (Director) $0 $0 $0
Maurice Emery Pharmd Phd (Director) $0 $0 $0
Anne C Heatherington Phd (Director) $0 $0 $0
Sean Hennessy Pharmd Phd (Director) $0 $0 $0
Virginia Ginny D Schmith Phd Fcp (Director) $0 $0 $0
David Y Mitchell Phd (Director) $0 $0 $0
Aubrey Stoch Md (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$3,599,868
Expenses
$3,740,444
Net Income
-$140,576
Net Assets
$5,138,868
Notable Sources of Revenue Percent of Total Revenue
Contributions $99,311
2.8%
Program Services $3,348,943
93.0%
Investment Income $74,049
2.1%
Bond Proceeds $0
Royalties $18,060
0.5%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $52,543
1.5%
Net Inventory Sales $0
Other Revenue $6,962
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $618,118
16.5%
Professional Fundraising Fees $0
Other Salaries and Wages $567,386
15.2%
Assets/Debt
Total Assets $5,268,980
Total Liabilities $130,112
Net Assets $5,138,868
Compensation
Key Employees and Officers Compensation Related Other
Sharon J Swan Fasae Cae (Chief Executive Officer) $384,411 $0 $43,363
Elise Laffman Johnson (Chief Operating Officer) $174,038 $0 $12,303
Kellie Reynolds Pharm D (President) $0 $0 $0
Dan Hartman Md Fccp (President Elect) $0 $0 $0
Julie A Johnson Pharm D (Immediate Past President) $0 $0 $0
Walter Kraft Md Facp (Treasurer) $0 $0 $0
Anne C Heatherington Ph D (Director) $0 $0 $0
Sean Hennessy Pharm D Ph D (Director) $0 $0 $0
David Y Mitchell Ph D (Director) $0 $0 $0
Virginia Ginny D Schmith Ph D Fcp (Director) $0 $0 $0
Jill Fiedler Kelly Phd (Director) $0 $0 $0
Aubrey Stoch Md (Director) $0 $0 $0
Paolo Vicini Ph D Mba (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$2,935,595
Expenses
$3,253,137
Net Income
-$317,542
Net Assets
$5,197,907
Notable Sources of Revenue Percent of Total Revenue
Contributions $30,259
1.0%
Program Services $1,844,898
62.8%
Investment Income $89,487
3.0%
Bond Proceeds $0
Royalties $963,955
32.8%
Rental Property Income $0
Net Fundraising $0
Sales of Assets $3,447
0.1%
Net Inventory Sales $0
Other Revenue $3,549
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $601,450
18.5%
Professional Fundraising Fees $0
Other Salaries and Wages $430,675
13.2%
Assets/Debt
Total Assets $5,370,032
Total Liabilities $172,125
Net Assets $5,197,907
Compensation
Key Employees and Officers Compensation Related Other
Sharon J Swan (Chief Executive Officer) $401,745 $0 $42,205
Elise S Laffman Johnson (Chief Operating Officer) $157,500 $0 $0
Mario Rocci Jr Phd (President) $0 $0 $0
Julie A Johnson Pharm D (President Elect) $0 $0 $0
David Y Mitchell Ph D (Immediate Past President) $0 $0 $0
Gregory L Kearns Pharmdphd (Secretary/Treasurer) $0 $0 $0
Kim L Rowse Brouwer Pharmd Phd (Board Member) $0 $0 $0
Maurice Emery Pharmd Phd (Board Member) $0 $0 $0
Anne C Heatherington Ph D (Board Member) $0 $0 $0
Sean Hennessy Pharm D Ph D (B Oard Member) $0 $0 $0
Walter Kraft Md Facp (Board Member) $0 $0 $0
Kellie Schoolar Reynolds Pharmd (Board Member) $0 $0 $0
Anne Zajicek Md Pharm D (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$3,313,990
Expenses
$2,769,298
Net Income
$544,692
Net Assets
$5,594,818
Notable Sources of Revenue Percent of Total Revenue
Contributions $46,169
1.4%
Program Services $2,387,231
72.0%
Investment Income $96,095
2.9%
Bond Proceeds $0
Royalties $766,010
23.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$12,756
Net Inventory Sales $0
Other Revenue $31,241
0.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $393,403
14.2%
Professional Fundraising Fees $3,782
0.1%
Other Salaries and Wages $485,851
17.5%
Assets/Debt
Total Assets $5,813,029
Total Liabilities $218,211
Net Assets $5,594,818
Compensation
Key Employees and Officers Compensation Related Other
Sharon J Swan (Chief Executive Officer) $361,296 $0 $32,108
John A Wagner Phd (President) $0 $0 $0
Russ Altman Md Phd (Immediate Past President) $0 $0 $0
Gregory L Kearns Pharmdphd (Secretary Treasurer) $0 $0 $0
Saskia De Wildt Md Phd (Board Member) $0 $0 $0
Maurice Emery Pharmd Phd (Board Member) $0 $0 $0
Walter Kraft Md Facp (Board Member) $0 $0 $0
Kellie Schoolar Reynolds Pharmd (Board Member) $0 $0 $0
Anne Zajicek Md Pharmd (Board Member) $0 $0 $0
Mario Rocci Jr Phd (President Elect) $0 $0 $0
Kim L Rowse Brouwer Pharmd Phd (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$2,768,829
Expenses
$2,666,553
Net Income
$102,276
Net Assets
$4,974,333
Notable Sources of Revenue Percent of Total Revenue
Contributions $88,684
3.2%
Program Services $1,663,807
60.1%
Investment Income $81,148
2.9%
Bond Proceeds $0
Royalties $972,218
35.1%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$38,913
Net Inventory Sales $0
Other Revenue $1,885
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $400,412
15.0%
Professional Fundraising Fees $9,350
0.4%
Other Salaries and Wages $402,681
15.1%
Assets/Debt
Total Assets $5,226,153
Total Liabilities $251,820
Net Assets $4,974,333
Compensation
Key Employees and Officers Compensation Related Other
Sharon J Swan (Chief Executive Officer) $359,660 $0 $39,749
Russ Altman Md Phd (President) $0 $0 $0
Kathleen M Giacomini Phd (Immediate Past President) $0 $0 $0
Gregory L Kearns Pharmdphd (Secretary Treasurer) $0 $0 $0
Andrea Gaedigkms Phd (Board Member) $0 $0 $0
Dhanesh K Gupta Md (Board Member) $0 $0 $0
Malle Jurima Romet Phd (Board Member) $0 $0 $0
James J Keirns Phd (Board Member) $0 $0 $0
Saskia De Wildt Md Phd (Board Member) $0 $0 $0
Keith D Wilner Phd (Board Member) $0 $0 $0
Anne Zajicek Md Pharmd (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$3,220,107
Expenses
$2,954,312
Net Income
$265,795
Net Assets
$4,683,325
Notable Sources of Revenue Percent of Total Revenue
Contributions $113,713
3.5%
Program Services $1,997,339
62.0%
Investment Income $65,687
2.0%
Bond Proceeds $0
Royalties $1,026,571
31.9%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$1,504
Net Inventory Sales $0
Other Revenue $18,301
0.6%
Notable Expenses Percent of Total Expenses
Executive Compensation $377,690
12.8%
Professional Fundraising Fees $2,291
0.1%
Other Salaries and Wages $415,989
14.1%
Assets/Debt
Total Assets $4,977,245
Total Liabilities $293,920
Net Assets $4,683,325

Document Links

Fiscal Year Ending Dec.
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$2,638,561
Expenses
$2,583,442
Net Income
$55,119
Net Assets
$4,305,539
Notable Sources of Revenue Percent of Total Revenue
Contributions $185,561
7.0%
Program Services $1,581,327
59.9%
Investment Income $60,114
2.3%
Bond Proceeds $0
Royalties $814,290
30.9%
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$9,268
Net Inventory Sales $0
Other Revenue $6,537
0.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $366,375
14.2%
Professional Fundraising Fees $0
Other Salaries and Wages $358,151
13.9%
Assets/Debt
Total Assets $4,643,996
Total Liabilities $338,457
Net Assets $4,305,539

Document Links

Fiscal Year Ending Dec.
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Jan.
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2006

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2005

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2004

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2003

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2002

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2001

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »